The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
2SEVENTY BIO ORD | COMMON STOCK ADDED | 901384107 | 49,134 | 1,917,063 | SH | SOLE | 1,917,063 | 0 | 0 | ||
5 01 ACQUISITION CORP | COM CL A | 33836P105 | 1,970 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
AC IMMUNE SA | SHS | H00263105 | 3,710 | 749,585 | SH | SOLE | 749,585 | 0 | 0 | ||
ACADIA PHARMACEUTICALS INC | COM | 004225108 | 71,434 | 3,060,593 | SH | SOLE | 3,060,593 | 0 | 0 | ||
ADVERUM BIOTECHNOLOGIES INC | COM | 00773U108 | 1,842 | 1,046,700 | SH | SOLE | 1,046,700 | 0 | 0 | ||
AKOUOS INC | COM | 00973J101 | 16,796 | 1,975,984 | SH | SOLE | 1,975,984 | 0 | 0 | ||
ALECTOR INC | COM | 014442107 | 103,146 | 4,994,970 | SH | SOLE | 4,994,970 | 0 | 0 | ||
ALIGOS THERAPEUTICS INC | COM | 01626L105 | 1,081 | 91,044 | SH | SOLE | 91,044 | 0 | 0 | ||
ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 16,644 | 98,146 | SH | SOLE | 98,146 | 0 | 0 | ||
ANAPTYSBIO INC | COM | 032724106 | 261,356 | 7,521,024 | SH | SOLE | 7,521,024 | 0 | 0 | ||
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 190,722 | 4,033,882 | SH | SOLE | 4,033,882 | 0 | 0 | ||
APPLIED MOLECULAR TRANS INC | COM | 03824M109 | 5,592 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
ARCUS BIOSCIENCES INC | COM | 03969F109 | 223,530 | 5,523,358 | SH | SOLE | 5,523,358 | 0 | 0 | ||
ARVINAS INC | COM | 04335A105 | 10,703 | 130,300 | SH | SOLE | 130,300 | 0 | 0 | ||
ARYA SCIENCES ACQU CORP IV | CL A | G31659108 | 1,487 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
ATEA PHARMACEUTICALS INC | COM | 04683R106 | 48,063 | 5,376,134 | SH | SOLE | 5,376,134 | 0 | 0 | ||
AVIDITY BIOSCIENCES INC | COM | 05370A108 | 65,593 | 2,759,505 | SH | SOLE | 2,759,505 | 0 | 0 | ||
BCLS ACQUISITION CORP | COM CL A | G0904B105 | 1,960 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
BOLT BIOTHERAPEUTICS INC | COM | 097702104 | 735 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
C4 THERAPEUTICS INC | COM STK | 12529R107 | 6,440 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
CAREMAX INC | *W EXP 06/08/202 | 14171W111 | 768 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
CARIBOU BIOSCIENCES INC | COM | 142038108 | 1,132 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
CENTESSA PHARMACEUTICALS PLC | SPONSORED ADS | 152309100 | 9,933 | 882,176 | SH | SOLE | 882,176 | 0 | 0 | ||
CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | 16,767 | 590,169 | SH | SOLE | 590,169 | 0 | 0 | ||
CRISPR THERAPEUTICS AG | NAMEN AKT | H17182108 | 81,652 | 1,077,483 | SH | SOLE | 1,077,483 | 0 | 0 | ||
DESIGN THERAPEUTICS INC | COM | 25056L103 | 46,096 | 2,152,997 | SH | SOLE | 2,152,997 | 0 | 0 | ||
DYNE THERAPEUTICS INC | COM | 26818M108 | 2,556 | 215,000 | SH | SOLE | 215,000 | 0 | 0 | ||
EDGEWISE THERAPEUTICS INC | COM | 28036F105 | 19,546 | 1,279,175 | SH | SOLE | 1,279,175 | 0 | 0 | ||
ERASCA INC | COM | 29479A108 | 10,906 | 700,000 | SH | SOLE | 700,000 | 0 | 0 | ||
EUCRATES BIOMEDICAL ACQU COR | SHS | G3141W106 | 1,952 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
EUCRATES BIOMEDICAL ACQU COR | *W EXP 10/23/202 | G3141W122 | 651 | 66,666 | SH | SOLE | 66,666 | 0 | 0 | ||
FRAZIER LIFESCIENCES ACQU CO | *W EXP 11/30/202 | G3710A113 | 650 | 66,665 | SH | SOLE | 66,665 | 0 | 0 | ||
FRAZIER LIFESCIENCES ACQU CO | SHS | G3710A105 | 5,729 | 587,615 | SH | SOLE | 587,615 | 0 | 0 | ||
GALAPAGOS NV | SPON ADR | 36315X101 | 122,631 | 2,224,403 | SH | SOLE | 2,224,403 | 0 | 0 | ||
GRAPHITE BIO INC | COM | 38870X104 | 8,563 | 688,900 | SH | SOLE | 688,900 | 0 | 0 | ||
GRITSTONE BIO INC | COM | 39868T105 | 77,317 | 6,012,232 | SH | SOLE | 6,012,232 | 0 | 0 | ||
GRITSTONE BIO INC | COM | 39868T105 | 3,948 | 307,000 | SH | Call | SOLE | 307,000 | 0 | 0 | |
HALOZYME THERAPEUTICS INC | COM | 40637H109 | 15,762 | 392,000 | SH | SOLE | 392,000 | 0 | 0 | ||
HEALTH SCIENCES ACQ CORP 2 ORD | SHS | G4411D109 | 4,032 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
HELIX ACQUISITION CORP | COM CL A | G4444C102 | 1,978 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
IMMUNOVANT INC | COM | 45258J102 | 9,720 | 1,140,819 | SH | SOLE | 1,140,819 | 0 | 0 | ||
ITEOS THERAPEUTICS INC | COM | 46565G104 | 60,675 | 1,303,157 | SH | SOLE | 1,303,157 | 0 | 0 | ||
JANUX THERAPEUTICS INC | COM | 47103J105 | 27,858 | 1,411,975 | SH | SOLE | 1,411,975 | 0 | 0 | ||
JIYA ACQUISITION CORP | COM CL A | 47760M102 | 4,885 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
KINNATE BIOPHARMA INC | COM | 49705R105 | 3,101 | 175,000 | SH | SOLE | 175,000 | 0 | 0 | ||
KRONOS BIO INC | COM | 50107A104 | 5,264 | 387,357 | SH | SOLE | 387,357 | 0 | 0 | ||
KURA ONCOLOGY INC | COM | 50127T109 | 52,142 | 3,724,437 | SH | SOLE | 3,724,437 | 0 | 0 | ||
LEGEND BIOTECH CORP | SPONSORED ADS | 52490G102 | 14,337 | 307,594 | SH | SOLE | 307,594 | 0 | 0 | ||
MONTE ROSA THERAPEUTICS INC | COM | 61225M102 | 768 | 37,593 | SH | SOLE | 37,593 | 0 | 0 | ||
MORPHIC HLDG INC | COM | 61775R105 | 187,225 | 3,951,566 | SH | SOLE | 3,951,566 | 0 | 0 | ||
NEOLEUKIN THERAPEUTICS INC | COM | 64049K104 | 4,148 | 860,619 | SH | SOLE | 860,619 | 0 | 0 | ||
NURIX THERAPEUTICS INC | COM | 67080M103 | 8,961 | 309,540 | SH | SOLE | 309,540 | 0 | 0 | ||
NUVATION BIO INC | *W EXP 07/07/202 | 67080N119 | 8,188 | 963,333 | SH | SOLE | 963,333 | 0 | 0 | ||
NUVATION BIO INC | COM CL A | 67080N101 | 118,121 | 13,896,543 | SH | SOLE | 13,896,543 | 0 | 0 | ||
OMEGA ALPHA SPAC | CL A | G6749V107 | 489 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
ORIC PHARMACEUTICALS INC | COM | 68622P109 | 50,993 | 3,468,944 | SH | SOLE | 3,468,944 | 0 | 0 | ||
OVID THERAPEUTICS INC | COM | 690469101 | 19,524 | 6,082,200 | SH | SOLE | 6,082,200 | 0 | 0 | ||
PARDES BIOSCIENCES ORD | COM ADDED | 69945Q105 | 26,145 | 1,597,139 | SH | SOLE | 1,597,139 | 0 | 0 | ||
PMV PHARMACEUTICALS INC | COM | 69353Y103 | 1,155 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 90,278 | 2,639,706 | SH | SOLE | 2,639,706 | 0 | 0 | ||
PROTHENA CORP PLC | SHS | G72800108 | 557,443 | 11,284,280 | SH | SOLE | 11,284,280 | 0 | 0 | ||
RELAY THERAPEUTICS INC | COM | 75943R102 | 54,636 | 1,779,084 | SH | SOLE | 1,779,084 | 0 | 0 | ||
REPARE THERAPEUTICS INC | COM | 760273102 | 1,055 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
SAGE THERAPEUTICS INC | COM | 78667J108 | 40,015 | 940,636 | SH | SOLE | 940,636 | 0 | 0 | ||
SILVERBACK THERAPEUTICS INC | COM | 82835W108 | 7,060 | 1,060,010 | SH | SOLE | 1,060,010 | 0 | 0 | ||
SOLID BIOSCIENCES INC | COM | 83422E105 | 16,105 | 9,202,702 | SH | SOLE | 9,202,702 | 0 | 0 | ||
SURROZEN INC | COM | 86889P117 | 429 | 66,665 | SH | SOLE | 66,665 | 0 | 0 | ||
TANGO THERAPEUTICS INC | COM | 87583X109 | 14,222 | 1,300,000 | SH | SOLE | 1,300,000 | 0 | 0 | ||
TURMERIC ACQUISITION CORP | CL A | G9127T108 | 982 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
TURMERIC ACQUISITION CORP | *W EXP 10/08/202 | G9127T124 | 327 | 33,333 | SH | SOLE | 33,333 | 0 | 0 | ||
VAXCYTE INC | COM | 92243G108 | 495 | 20,800 | SH | SOLE | 20,800 | 0 | 0 | ||
VENTYX BIOSCIENCES ORD | COM ADDED | 92332V107 | 25,818 | 1,300,000 | SH | SOLE | 1,300,000 | 0 | 0 | ||
VERVE THERAPEUTICS INC | COM | 92539P101 | 3,687 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
VOYAGER THERAPEUTICS INC | COM | 92915B106 | 9,641 | 3,557,507 | SH | SOLE | 3,557,507 | 0 | 0 | ||
VTV THERAPEUTICS INC | CL A | 918385105 | 830 | 834,333 | SH | SOLE | 834,333 | 0 | 0 | ||
XENCOR INC | COM | 98401F105 | 196,833 | 4,906,106 | SH | SOLE | 4,906,106 | 0 | 0 |